Skip to main content

J&J Cleared Over Asbestos Cancer Claims Linked To Talcum

J&J Cleared Over Asbestos Cancer Claims Linked To Talcum

J&J Cleared Over Asbestos Cancer Claims Linked To Talcum

Introduction

Following almost a seven-week long jury trial, Johnson & Johnson was successful in persuading a California jury to dismiss claims made by a woman that the asbestos presence in its talcum baby powder caused her to develop malignant mesothelioma.  

The plaintiff alleged that J&J knew of asbestos fibers in its talc-based products and concealed the risks associated with them. Though the Eureka State Jury agreed the plaintiff was exposed to asbestos-tainted baby powder but reasoned wasn’t a “substantial factor” in causing her cancer.

J&J released a statement in response to its latest win stating, "While we deeply sympathize with anyone suffering from any form of cancer, the science and facts show that her disease was not caused by her use of our talcum-based products". A company spokesperson further said, ''decades of clinical evidence and scientific studies by medical experts around the world support the safety of Johnson’s Baby Powder.”

J&J is also one of the main defendants involved in fighting more than 9,700 talc ovarian cancer lawsuits for several years.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

First Federal Bellwether Trial Set in Strattice Mesh Case

Categories: Hernia Mesh

Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…

Tepezza Hearing Loss Trial Set for June 2026

Categories: Tepezza

The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.

This decision comes as attorneys…

FDA Moves to Restrict Dangerous 7-OH Opioid Products

Categories: Opioids

In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!